MAGEA3 and urinary bladder carcinoma: Due to their highly antigenic properties and other diverse roles during cancer progression, the aberrant expression of MAGEA family, especially MAGEA3 and MAGEA6, may serve as prognostic biomarkers for poor outcomes in bladder cancer patients.